Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
Cyclacel Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
Cyclacel Pharmaceuticals reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, three executives at Cyclacel Pharmaceuticals received on average a compensation package of $897K, a 21% increase compared to previous year.
Average pay of disclosed executives at Cyclacel Pharmaceuticals
Spiro Rombotis, Chief Executive Officer, received $1.4M in total, which increased by 39% compared to 2019. 45% of Rombotis' compensation, or $637K, was in option awards. Rombotis also received $202K in bonus, $531K in salary, as well as $40K in other compensation.
Paul McBarron, Chief Financial Officer, received a compensation package of $829K, which increased by 53% compared to previous year. 53% of the compensation package, or $437K, was in option awards.
Mark Kirschbaum, Chief Medical Officer, earned $454K in 2020.
Related executives
You may also like
Source: SEC filing on April 29, 2021.